M. Martín

Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study

L. Aguilar, M. Giménez, J. Prieto, 1997, Antimicrobial agents and chemotherapy.

Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation

R. Dal-Ré, L. Aguilar, J. Prieto, 1996, Antimicrobial agents and chemotherapy.

Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.

J. Izquierdo, M. Gómez-Lus, M. Martín, 1996, Chemotherapy.

Postantibiotic and Sub-MIC Effects of Azithromycin and Isepamicin against Staphylococcus aureus and Escherichia coli

J. Izquierdo, M. Gómez-Lus, M. Martín, 1998, Antimicrobial Agents and Chemotherapy.

Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers

P. Salvà, R. Dal-Ré, J. Costa, 1996, Antimicrobial agents and chemotherapy.

In vivo and in vitro study of several pharmacodynamic effects of meropenem.

J. Izquierdo, M. Gómez-Lus, M. Martín, 1995, Scandinavian journal of infectious diseases.

Effect of polymorphonuclear neutrophils on serum bactericidal activity againstStreptococcus pneumoniae after amoxicillin administration

L. Aguilar, M. Giménez, J. Prieto, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens

R. Dal-Ré, L. Aguilar, J. Prieto, 1997, Antimicrobial agents and chemotherapy.

Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity againstStreptococcus pneumoniae

L. Aguilar, M. Giménez, P. Martínez, 1997, European Journal of Clinical Microbiology and Infectious Diseases.